Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression

Journal of Experimental Medicine

Volumn 207, Issue 12, 2010, Pages 2551-2559

  Albring, Jörn C ^a   Sandau, Michelle M ^a   Rapaport, Aaron S ^a   Edelson, Brian T ^a   Satpathy, Ansuman ^a   Mashayekhi, Mona ^a   Lathrop, Stephanie K ^a   Hsieh, Chyi Song ^a   Stelljes, Matthias ^b   Colonna, Marco ^a   Murphy, Theresa L ^a   Murphy, Kenneth M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

B AND T LYMPHOCYTE ASSOCIATED; HERPESVIRUS ENTRY MEDIATOR; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6A6; MONOCLONAL ANTIBODY 6F7; MONOCLONAL ANTIBODY PIP; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOSUPPRESSION; LISTERIOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 14; T-LYMPHOCYTES, REGULATORY;

EID: 78649394507     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20102017     Document Type: Article

References (35)

1. Blazar, B.R., B.M. Carreno, A. Panoskaltsis-Mortari, L. Carter, Y. Iwai, H. Yagita, H. Nishimura, and P.A. Taylor. 2003. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism. J. Immunol. 171:1272-1277.
2. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 198:1875-1886. doi:10.1084/jem.20030152
3. Cooke, K.R., L. Kobzik, T.R. Martin, J. Brewer, J. Delmonte Jr., J.M. Crawford, and J.L.M. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood. 88:3230-3239.
4. Copelan, E.A. 2006. Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354:1813-1826. doi:10.1056/NEJMra052638
5. Edinger, M., Y.A. Cao, M.R. Verneris, M.H. Bachmann, C.H. Contag, and R.S. Negrin. 2003a. Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging. Blood. 101:640-648. doi:10.1182/blood2002061751
6. Edinger, M., P. Hoffmann, J. Ermann, K. Drago, C.G. Fathman, S. Strober, and R.S. Negrin. 2003b. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat. Med. 9:1144-1150. doi:10.1038/nm915
7. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341. doi:10.1016/j.immuni.2005.01. 016
8. Gavrieli, M., and K.M. Murphy. 2006. Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLA. Biochem. Biophys. Res. Commun. 345:1440-1445. doi:10.1016/j.bbrc.2006.05.036
9. Gronowski, A.M., D.M. Hilbert, K.C.F. Sheehan, G. Garotta, and R.D. Schreiber. 1999. Baculovirus stimulates antiviral effects in mammalian cells. J. Virol. 73:9944-9951.
10. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science. 299:1057-1061. doi:10.1126/science.1079490
11. Hurchla, M.A., J.R. Sedy, M. Gavrieli, M. Gavrielli, C.G. Drake, T.L. Murphy, and K.M. Murphy. 2005. B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly induced in anergic CD4+ T cells. J. Immunol. 174:3377-3385.
12. Hurchla, M.A., J.R. Sedy, and K.M. Murphy. 2007. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation. J. Immunol. 178:6073-6082.
13. Kawai, T., A.B. Cosimi, T.R. Spitzer, N. Tolkoff-Rubin, M. Suthanthiran, S.L. Saidman, J. Shaffer, F.I. Preffer, R.C. Ding, V. Sharma, et al. 2008. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358:353-361. doi:10.1056/NEJMoa071074
14. Kim, J.M., J.P. Rasmussen, and A.Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8:191-197. doi:10.1038/ni1428
15. Krug, A., A.R. French, W. Barchet, J.A.A. Fischer, A. Dzionek, J.T. Pingel, M.M. Orihuela, S. Akira, W.M. Yokoyama, and M. Colonna. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity. 21:107-119. doi:10.1016/j.immuni.2004.06.007 (Pubitemid 38925271)
16. Lepenies, B., K. Pfeffer, M.A. Hurchla, T.L. Murphy, K.M. Murphy, J. Oetzel, B. Fleischer, and T. Jacobs. 2007. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria. J. Immunol. 179:4093-4100.
17. Liu, X.K., M. Alexiou, N. Martin-Orozco, Y. Chung, R.I. Nurieva, L. Ma, Q. Tian, G. Kollias, S. Lu, D. Graf, and C. Dong. 2009. Cutting edge: A critical role of B and T lymphocyte attenuator in peripheral T cell tolerance induction. J. Immunol. 182:4516-4520. doi:10.4049/jimmunol.0803161
18. Lu, Y., S. Sakamaki, H. Kuroda, T. Kusakabe, Y. Konuma, T. Akiyama, A. Fujimi, N. Takemoto, K. Nishiie, T. Matsunaga, et al. 2001. Prevention of lethal acute graft-versus-host disease in mice by oral administration of T helper 1 inhibitor, TAK-603. Blood. 97:1123-1130. doi:10.1182/blood.V97.4.1123
19. McSweeney, P.A., D. Niederwieser, J.A. Shizuru, B.M. Sandmaier, A.J. Molina, D.G. Maloney, T.R. Chauncey, T.A. Gooley, U. Hegenbart, R.A. Nash, et al. 2001. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood. 97:3390-3400. doi:10.1182/blood.V97.11.3390
20. Miura, T., D. Mizuki, S. Sasaki, S. Hasegawa, H. Sashinami, and A. Nakane. 2000. Host resistance to Listeria monocytogenes infection is enhanced but resistance to Staphylococcus aureus infection is reduced in acute graft-versus-host disease in mice. Infect. Immun. 68:4340-4343. doi:10.1128/IAI.68.7.43404343.2000
21. Nguyen, V.H., S. Shashidhar, D.S. Chang, L. Ho, N. Kambham, M. Bachmann, J.M. Brown, and R.S. Negrin. 2008. The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation. Blood. 111:945-953. doi:10.1182/blood200707103895
22. Petersdorf, E.W., C. Anasetti, P.J. Martin, T. Gooley, J. Radich, M. Malkki, A. Woolfrey, A. Smith, E. Mickelson, and J.A. Hansen. 2004. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood. 104:2976-2980. doi:10.1182/blood2004041674
23. Ranganath, S., W. Ouyang, D. Bhattarcharya, W.C. Sha, A. Grupe, G. Peltz, and K.M. Murphy. 1998. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161:3822-3826.
24. Rehemtulla, A., L.D. Stegman, S.J. Cardozo, S. Gupta, D.E. Hall, C.H. Contag, and B.D. Ross. 2000. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 2:491-495. doi:10.1038/sj.neo.7900121
25. Sedy, J.R., M. Gavrieli, K.G. Potter, M.A. Hurchla, R.C. Lindsley, K. Hildner, S. Scheu, K. Pfeffer, C.F. Ware, T.L. Murphy, and K.M. Murphy. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat. Immunol. 6:90-98. doi:10.1038/ni1144
26. Steinberg, M.W., O. Turovskaya, R.B. Shaikh, G. Kim, D.F. McCole, K. Pfeffer, K.M. Murphy, C.F. Ware, and M. Kronenberg. 2008. A crucial role for HVEM and BTLA in preventing intestinal inflammation. J. Exp. Med. 205:1463-1476. doi:10.1084/jem.20071160
27. Stelljes, M., S. Hermann, J. Albring, G. Köhler, M. Löffler, C. Franzius, C. Poremba, V. Schlösser, S. Volkmann, C. Opitz, et al. 2008. Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography. Blood. 111:2909-2918. doi:10.1182/blood-2007-10-119164
28. Sykes, M., and B. Nikolic. 2005. Treatment of severe autoimmune disease by stem-cell transplantation. Nature. 435:620-627. doi:10.1038/nature03728 (Pubitemid 40825502)
29. Tamada, K., K. Shimozaki, A.I. Chapoval, G. Zhu, G. Sica, D. Flies, T. Boone, H. Hsu, Y.X. Fu, S. Nagata, et al. 2000. Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat. Med. 6:283-289. doi:10.1038/73136
30. Taylor, P.A., C.J. Lees, and B.R. Blazar. 2002. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 99:3493-3499. doi:10.1182/blood.V99. 10.3493
31. Truong, W., W.W. Hancock, J.C. Plester, S. Merani, D.C. Rayner, G. Thangavelu, K.M. Murphy, C.C. Anderson, and A.M. Shapiro. 2009. BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J. Leukoc. Biol. 86:41-51. doi:10.1189/jlb.1107753
32. Wang, Y., S.K. Subudhi, R.A. Anders, J. Lo, Y. Sun, S. Blink, Y. Wang, J. Wang, X. Liu, K. Mink, et al. 2005. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. J. Clin. Invest. 115:711-717.
33. Watanabe, N., M. Gavrieli, J.R. Sedy, J. Yang, F. Fallarino, S.K. Loftin, M.A. Hurchla, N. Zimmerman, J. Sim, X. Zang, et al. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat. Immunol. 4:670-679. doi:10.1038/ni944
34. Wu, T.H., Y. Zhen, C. Zeng, H.F. Yi, and Y. Zhao. 2007. B and T lymphocyte attenuator interacts with CD3zeta and inhibits tyrosine phosphorylation of TCRzeta complex during T-cell activation. Immunol. Cell Biol. 85:590-595. doi:10.1038/sj.icb.7100087
35. Xu, Y., A.S. Flies, D.B. Flies, G. Zhu, S. Anand, S.J. Flies, H. Xu, R.A. Anders, W.W. Hancock, L. Chen, and K. Tamada. 2007. Selective targeting of the LIGHTH-VEM costimulatory system for the treatment of graft-versus-host disease. Blood. 109:4097-4104. doi:10.1182/blood200609047332